These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10155297)

  • 21. Cefaclor therapy for specific upper respiratory tract infections: pharyngitis, purulent rhinitis, laryngotracheitis.
    Carbon C
    Clin Ther; 1988; 11 Suppl A():48-53. PubMed ID: 3072085
    [No Abstract]   [Full Text] [Related]  

  • 22. [Reevaluation of current antimicrobials. Cefaclor].
    Sunakawa K; Shiba K
    Jpn J Antibiot; 1994 Jul; 47(7):853-60. PubMed ID: 7933517
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefaclor revisited.
    Meyers BR
    Clin Ther; 2000 Feb; 22(2):154-66. PubMed ID: 10743978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of acute and bacterial lower respiratory tract infections with roxithromycin].
    Chabbou A; Belalgia S; Kamel A; Megdiche L
    Tunis Med; 1992 Oct; 70(10):467-71. PubMed ID: 1295159
    [No Abstract]   [Full Text] [Related]  

  • 25. Open clinical trial of roxithromycin amongst patients of Jos University Teaching Hospital with lower and upper respiratory tract infections.
    Idoko JA; Anteyi EA; Ighogboja IS; Ikeh EI
    West Afr J Med; 1995; 14(3):127-33. PubMed ID: 8519697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy with cefaclor: analysis of infections in 189 French patients.
    Masbernard A; Salord JC
    Postgrad Med J; 1979; 55 Suppl 4():72-6. PubMed ID: 398484
    [No Abstract]   [Full Text] [Related]  

  • 27. [Report of experiences with the oral cephalosporin-derivative cephaclor in respiratory tract infections].
    Spath P
    Wien Med Wochenschr; 1983 Jan; 133(1):27-30. PubMed ID: 6837048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory tract infections].
    Aonuma S; Oizumi K; Watanabe A; Tokue Y; Honda Y; Ono R; Kitamura N; Konno K; Satoh K
    Jpn J Antibiot; 1988 Sep; 41(9):1309-12. PubMed ID: 3241329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open clinical trial of roxithromycin in patients of Plateau Hospitals, Jos in upper and lower respiratory tract infections.
    Okeke EN; Juryit Z; Ikeh EI
    West Afr J Med; 1995; 14(4):238-41. PubMed ID: 8634230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of treatment with cefaclor, a new oral cephalosporin].
    Fortschr Med; 1979 Oct; 97(38):1709-10. PubMed ID: 511065
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of roxithromycin on respiratory bacterial infection in mice.
    Gonokami Y; Konno S; Asano K; Kurokawa M; Kawazu K; Adachi M
    Arerugi; 1995 Jan; 44(1):45-9. PubMed ID: 7702454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of cefaclor in respiratory infections amongst Pakistani children.
    Najam Y; Walla FL; Iqbal A; Khan MK; Aqil S; Sharif MW; Masood T; Gaba I; Malik BA; Hassan M; Malik S; Hassan S; Bukhari KA; Khawar N; Tarar MA
    J Pak Med Assoc; 2000 Sep; 50(9):289-93. PubMed ID: 11043017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients.
    Isah AO; Ohaju-Obodo J
    West Afr J Med; 1996; 15(2):111-6. PubMed ID: 8855675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Personal experience with the use of Rulid (roxithromycin) in children less than 1 year of age].
    Jakubicka J; Dluholucký S
    Cesk Pediatr; 1993 Jan; 48(1):49-51. PubMed ID: 8477469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and microbiological evaluation of prodrug antibiotic SCE-2174. A new cephalosporin for oral use. A comparative open randomized study vs cefaclor in 50 patients with infections of the middle or lower respiratory tract].
    Girbino G; Giacobbe G; Fiorello G; Condoluci M; Molonia N
    Arch Monaldi Mal Torace; 1988; 43(6):533-43. PubMed ID: 3155015
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acute seasonal respiratory tract infections. Even legionellas participate significantly].
    MMW Fortschr Med; 2000 Nov; 142(44):52. PubMed ID: 11107810
    [No Abstract]   [Full Text] [Related]  

  • 37. The acceptability, efficacy and safety of a new paediatric oral suspension of roxithromycin in respiratory tract infections.
    Moniot-Ville N; Chelly M; Consten L; Rosenbaum M
    J Int Med Res; 1998; 26(3):144-51. PubMed ID: 9718469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Revaluation of current antimicrobials. Series 18: Roxithromycin].
    Niki Y; Tamaoki J
    Jpn J Antibiot; 1994 Oct; 47(10):1275-82. PubMed ID: 7807689
    [No Abstract]   [Full Text] [Related]  

  • 40. Is roxithromycin better than amoxicillin in the treatment of acute lower respiratory tract infections in primary care? A double-blind randomized controlled trial.
    Hopstaken RM; Nelemans P; Stobberingh EE; Muris JW; Rinkens PE; Dinant GJ
    J Fam Pract; 2002 Apr; 51(4):329-36. PubMed ID: 11978255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.